Gordon is actively involved in the biotechnology sector as an entrepreneur. Quadriga, an oncology start-up, is dedicated to the development of targeted anti-cancer medications. In addition to his current role at Maverix Biomics, a bio-informatics company co-founded by Prof Todd Lowe (UCSC), Gordon serves on the board of directors for Ardelyx, Alexza, and 3V Biopharma. Over the years, he has held various positions, including Co-Founder and/or CEO of Maxygen, SurroMed, Alexza, and Alavita. Moreover, Gordon previously served as CEO and Scientific Director of Affymax Research Institute (acquired by Glaxo in 1995) from 1991 to 2000, overseeing the advancement of innovative technologies.